sr 48692 has been researched along with haloperidol in 10 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dix, TA; Hadden, MK; Lassetter, MR; Orwig, KS | 1 |
| Gully, D; Le Fur, G; Mons, G; Rodier, D; Soubrié, P; Steinberg, R | 1 |
| Gross, R; Kilts, CD; Lambert, PD; Nemeroff, CB | 1 |
| Brun, P; Le Fur, G; Soubrié, P; Steinberg, R | 1 |
| Cheung, S; Hentschel, K; Lookingland, KJ; Moore, KE | 1 |
| Gueudet, C; Michaud, JC; Soubrié, P | 1 |
| Deutch, AY; Dobner, PR; Fadel, J | 1 |
| Brun, P; Leonetti, M; Renaud, B; Sotty, F; Soubrié, P; Steinberg, R; Suaud-Chagny, MF | 1 |
| Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S | 1 |
| Chartoff, EH; Dorsa, DM; Palmiter, RD; Szczypka, MS | 1 |
1 review(s) available for sr 48692 and haloperidol
| Article | Year |
|---|---|
Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Cyclic AMP; Dopamine; Haloperidol; Neurotensin; Pyrazoles; Quinolines; Receptors, Dopamine; Receptors, Neurotensin; Schizophrenia; Signal Transduction | 1995 |
9 other study(ies) available for sr 48692 and haloperidol
| Article | Year |
|---|---|
Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
Topics: Aminopeptidases; Animals; Binding, Competitive; Body Temperature; Calcium; Cell Line; Humans; In Vitro Techniques; Intracellular Space; Male; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Structure-Activity Relationship | 2009 |
SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum.
Topics: Acetylcholine; Animals; Corpus Striatum; Haloperidol; Male; Microdialysis; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 1995 |
Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Topics: Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Electrodes; Haloperidol; Kainic Acid; Male; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 1995 |
Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Binding, Competitive; Dopamine; Dopamine Antagonists; Female; Haloperidol; Male; Median Eminence; Neurons; Neurotensin; Prolactin; Pyrazoles; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotensin; Sex Factors | 1998 |
Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons.
Topics: Action Potentials; Animals; Clozapine; Dopamine Antagonists; Electrophysiology; Globus Pallidus; Haloperidol; Male; Neurons; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Serotonin Antagonists | 2000 |
The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.
Topics: Animals; Corpus Striatum; Dopamine Antagonists; Gene Expression; Genes, fos; Haloperidol; Male; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 2001 |
Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Topics: Adamantane; Animals; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Electrochemistry; Haloperidol; Imidazoles; Male; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stimulation, Chemical | 2001 |
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
Topics: Adamantane; Analysis of Variance; Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Imidazoles; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyrazoles; Quinolines; Receptors, Neurotensin | 2004 |
Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Topics: Age Factors; Animals; Behavior, Animal; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Gene Expression; Haloperidol; In Situ Hybridization; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Messenger; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2004 |